HLA-A*11 was previously reported to be a protective allele in EBV-associated undifferentiated nasopharyngeal carcinoma (UNPC) in both endemic and non-endemic regions [32], [33]. Here, HLA-A is linked to undifferentiated carcinoma of nasopharynx.